Literature DB >> 8055450

Ductal carcinoma in situ of the male breast.

M G Camus1, M G Joshi, G Mackarem, A K Lee, R L Rossi, J L Munson, J Buyske, L J Barbarisi, L E Sanders, K S Hughes.   

Abstract

BACKGROUND: Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and treatment of this disease are not well defined in the literature.
METHODS: Records of 23 men with carcinoma of the breast treated at the Lahey Clinic from 1968 to 1991 were reviewed, revealing 4 patients with pure DCIS (17%). The reported management of DCIS in women is discussed in comparison with that of DCIS in men.
RESULTS: Of the four patients with DCIS, the presenting complaint was a retroareolar mass in three patients and a bloody nipple discharge in one patient. The pathologic subtype was papillary in one patient and intracystic papillary in three patients. Two patients were treated with partial mastectomy alone. Disease recurred locally as DCIS in both patients, requiring mastectomy at 30 and 108 months. No lymph node metastases were found in the three patients who underwent axillary dissection. All four patients were alive without disease at 133, 120, 36, and 32 months of follow-up, respectively.
CONCLUSIONS: Although the sample size was small, our patients and a review of the literature suggest that most DCIS in men is of the papillary type and that mastectomy without axillary dissection is the preferred treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8055450     DOI: 10.1002/1097-0142(19940815)74:4<1289::aid-cncr2820740418>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Male breast cancer: presenting as synchronous, large, bilateral masses.

Authors:  Sunil Vitthalrao Jagtap; P G Chougule; Wasim Khatib; Dhirajkumar B Shukla; Swati Sunil Jagtap
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Ductal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastia.

Authors:  C J Coroneos; C Hamm
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

3.  Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.

Authors:  Seema Panchal; Orli Shachar; Frances O'Malley; Pavel Crystal; Jaime Escallon; Juanita Crook; Anita Bane; Louise Bordeleau
Journal:  Nat Rev Clin Oncol       Date:  2009-10       Impact factor: 66.675

4.  Ductal carcinoma in situ in a 15-year-old boy with gynaecomastia: a case report.

Authors:  Michele Corroppolo; Elena Erculiani; Nicola Zampieri; Marta Gobbato; Francesco Saverio Camoglio; Luca Giacomello
Journal:  Pediatr Surg Int       Date:  2008-07-05       Impact factor: 1.827

5.  Development and evaluation of a survey to assess survivor knowledge change after survivorship care plans: WiSDOM-B (Wisconsin Survey of cancer DiagnOsis and Management in Breast cancer).

Authors:  Gabrielle B Rocque; Kari B Wisinski; Kevin A Buhr; Jamie L Froeschner; Nathan Jones; Sarah Donohue; Douglas Wiegmann; Mary E Sesto; Amye J Tevaarwerk
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

6.  Asymptomatic Incidental Ductal Carcinoma in situ in a Male Breast Presenting with Contralateral Gynecomastia.

Authors:  Laura M Isley; Rebecca J Leddy; Tihana Rumboldt; Jacqueline M Bernard
Journal:  J Clin Imaging Sci       Date:  2012-03-19

7.  Magnetic resonance imaging findings of high-grade ductal carcinoma in situ of the male breast: A case report.

Authors:  Florian Reinhardt; Britta Mathys; Petra Reinecke; Hans Neubauer; Tanja Fehm; Svjetlana Mohrmann
Journal:  SAGE Open Med Case Rep       Date:  2018-06-12

8.  Angiogenesis in male breast cancer.

Authors:  Evan M Frangou; Joshua Lawson; Rani Kanthan
Journal:  World J Surg Oncol       Date:  2005-03-02       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.